Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Murrough

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Molecular Psychiatry|February 11, 2026
Major depressive disorder shares systemic immune signatures and potential therapeutic targets with inflammatory skin diseasesHelen He, Flurin Cathomas, Lyonna F Parise, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 29, 2026
KET-MCI: A Pilot Safety and Tolerability Study of Single Infusion Intravenous Ketamine for Older Adults with Depression and Mild Cognitive ImpairmentRachel Fremont, Amelia Karim, Tanya Peguero Estevez, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
Neuroimage|November 9, 2022
Ventral tegmental area integrity measured with high-resolution 7-Tesla MRI relates to motivation across depression and anxiety diagnosesLaurel S Morris, Marishka Mehta, Christopher Ahn, et al.
Biological Psychiatry|December 9, 2008
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorderRebecca B Price, Dikoma C Shungu, Xiangling Mao, et al.
The Journal of Clinical Psychiatry|December 14, 2022
Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-AnalysisRebecca S Hock, Anna Feeney, Nadia Iovieno, et al.
NPJ Digital Medicine|March 12, 2019
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depressionBrian M Iacoviello, James W Murrough, Megan M Hoch, et al.
Frontiers in Nutrition|December 13, 2021
Dissolution Study on Grape Polyphenol Hard Gelatin Capsule Dietary SupplementsWeiting Lyu, Thamer Omar, Harna Patel, et al.
Biological Psychiatry|August 23, 2011
Reduced amygdala serotonin transporter binding in posttraumatic stress disorderJames W Murrough, Yiyun Huang, Jian Hu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 16, 2024
Method development with high-throughput enhanced matrix removal followed by UHPLC-QqQ-MS/MS for analysis of grape polyphenol metabolites in human urineWeiting Lyu, Zhiya Yin, Lingjun Xie, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Molecular Psychiatry|February 11, 2026
Major depressive disorder shares systemic immune signatures and potential therapeutic targets with inflammatory skin diseasesHelen He, Flurin Cathomas, Lyonna F Parise, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 29, 2026
KET-MCI: A Pilot Safety and Tolerability Study of Single Infusion Intravenous Ketamine for Older Adults with Depression and Mild Cognitive ImpairmentRachel Fremont, Amelia Karim, Tanya Peguero Estevez, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
Neuroimage|November 9, 2022
Ventral tegmental area integrity measured with high-resolution 7-Tesla MRI relates to motivation across depression and anxiety diagnosesLaurel S Morris, Marishka Mehta, Christopher Ahn, et al.
Biological Psychiatry|December 9, 2008
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorderRebecca B Price, Dikoma C Shungu, Xiangling Mao, et al.
The Journal of Clinical Psychiatry|December 14, 2022
Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-AnalysisRebecca S Hock, Anna Feeney, Nadia Iovieno, et al.
NPJ Digital Medicine|March 12, 2019
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depressionBrian M Iacoviello, James W Murrough, Megan M Hoch, et al.
Frontiers in Nutrition|December 13, 2021
Dissolution Study on Grape Polyphenol Hard Gelatin Capsule Dietary SupplementsWeiting Lyu, Thamer Omar, Harna Patel, et al.
Biological Psychiatry|August 23, 2011
Reduced amygdala serotonin transporter binding in posttraumatic stress disorderJames W Murrough, Yiyun Huang, Jian Hu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 16, 2024
Method development with high-throughput enhanced matrix removal followed by UHPLC-QqQ-MS/MS for analysis of grape polyphenol metabolites in human urineWeiting Lyu, Zhiya Yin, Lingjun Xie, et al.
Pageof 18